After the first author admitted to fraud, his colleagues have retracted a 2013 paper in the Journal of Neuroscience, as well as a 2015 book chapter about working memory. The retractions come as part of a backstory of pulled papers authored by psychologist Edward Awh and his former graduate student David Anderson when he was based at the University … Continue reading Two more retractions bring total to 9 for neuroscience duo
The week at Retraction Watch featured a retraction from Nature, and a discussion of what it means to be an author on a paper with thousands of them. Here’s what was happening elsewhere:
The British Journal of Clinical Pharmacology (BJCP) has retracted a 2015 paper about treating heart failure after deciding its peer review process had been compromised. This paper is one of the many we’ve noticed lately that have been felled by the actions of a “third party” — in this case, a manuscript editing company called … Continue reading Pharmacology journal pulls paper because third party “compromised” peer review
A well-known scientist at the Massachusetts Institute of Technology who studies longevity has retracted a paper for “numerous examples of unindicated splicing of gel lanes,” as well as other problems. This is Leonard Guarente‘s second retraction. He shares both with Gizem Donmez, an alum of his lab who now has three retractions. Donmez left her post as a Tufts professor in … Continue reading Image splicing, duplications, inversions kill paper for well-known longevity researcher and alum of lab
Today colleges and universities face a crisis of accountability in two domains: scientific misconduct and sexual harassment or assault. Scientific misconduct and sexual harassment/assault are obviously different, but the way they are reported, handled, and play out have many similarities. Michael Chwe at the University of California in Los Angeles has been thinking about this for … Continue reading Scientific misconduct and sexual harassment: Similar problems with similar solutions?
A Danish court has determined that psychologist Helmuth Nyborg did not commit misconduct in a controversial 2011 paper which predicted an influx of immigrants into Denmark would lower the population’s average IQ by the latter part of this century. The ruling, reported by the Danish newspaper Politiken, overturns a previous finding of misconduct by the the Danish … Continue reading Denmark court clears controversial psychologist of misconduct charges
Authors have retracted a case report describing a surgery to remove gallstones in a patient with Crohn’s disease after learning they’d mixed up two cases, and instead reported on a patient who had died 21 days after the procedure. We were alerted to this story by La Repubblica, and contacted by the son of the patient … Continue reading Son sees dead father in case report, requests retraction
Four expressions of concern in the journal Diabetes have turned into retractions for Mario Saad, a move which he had tried to stop with a lawsuit. Last August, a judge dismissed Saad’s suit against the American Diabetes Association, which publishes Diabetes, concluding that the expressions of concerns on the papers were not defamation, but part of an “ongoing … Continue reading Lawsuit couldn’t stop four retractions for diabetes researcher
The University of Gothenburg in Sweden is investigating several papers co-authored by biologist Suchitra Sumitran-Holgersson after they were challenged on PubPeer. Sumitran-Holgersson already has one retraction under her belt — of a 2005 Blood paper, after another investigation concluded the results “cannot be considered reliable.” Sumitran-Holgersson and her husband, co-author Jan Holgersson, did not sign the retraction notice. Both were … Continue reading Biologist’s research under investigation in Sweden after being questioned on PubPeer
The U.S. Food and Drug Administration (FDA) has permanently debarred a clinical trial coordinator from working on drug applications after he swapped patient stool samples for his own, and pocketed the money earmarked for patients — along with forging patient records, lab work, and doctors’ signatures. The debarment is moot for time being — last … Continue reading FDA bans trial coordinator who pocketed patient funds and went to prison